title: [Current approaches to using beta-carotenoids in chronic hepatitis in flight personnel].
abstract: 48 patients from flying personnel with chronic diseases of the liver have been studied. Considering poor effectiveness of the available hepatotropic drugs, a new B-caratinoid, veteron, was used at different daily doses. Findings of this study allowed us to draw inferences not only about more efficient clinical effect of this preparation beginning from a daily dose of 160 mg/day but also about its immunomodulating and pro-oxidant action. Thus, veteron is optimal for patients with chronic disorders of the immunologic and antioxidant systems and can be effectively used in treatment of these diseases.
authors.forename: V N
authors.initials: VN
authors.lastname: Preobrazhenskiĭ
authors.forename: V V
authors.initials: VV
authors.lastname: Vasilenko
mesh_terms: D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D002908:Chronic Disease; D004341:Drug Evaluation; D006505:Hepatitis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D019207:beta Carotene / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D019207:beta Carotene
vernacular_title: Sovremennye podkhody k primeneniiu B-karatinoidov pri khronicheskikh gepatitakh u letnogo sostava.